Table 2.
Long time survival rate (CSS/OS) in colorectal cancer by age
| 15-30 | 31-40 | 41-50 | 51-60 | 61-70 | 71-80 | >80 | P value | |
|---|---|---|---|---|---|---|---|---|
| Total | (n = 1181) | (n = 5333) | (n = 18727) | (n = 39125) | (n = 53540) | (n = 64642) | (n = 43882) | |
| CSS | <0.001 | |||||||
| 1-year CCS | 84.6% | 88.8% | 88.8% | 88.7% | 86.8% | 82.8% | 74.2% | |
| 3-year CCS | 66.4% | 72.7% | 73.3% | 75.1% | 74.1% | 70.4% | 60.0% | |
| 5-year CCS | 58.5% | 65.7% | 66.3% | 68.0% | 67.6% | 64.0% | 53.5% | |
| OS | ||||||||
| 1-year OS | 83.5% | 87.9% | 87.8% | 87.2% | 83.9% | 77.3% | 63.8% | |
| 3-year OS | 64.8% | 71.0% | 71.6% | 72.4% | 68.9% | 60.5% | 43.0% | |
| 5-year OS | 56.6% | 63.6% | 63.5% | 64.0% | 60.0% | 49.9% | 30.5% | |
| Operated group | (n = 1073) | (n = 4874) | (n = 17025) | (n = 35729) | (n = 48909) | (n = 58248) | (n = 36890) | |
| 5-year CCS | <0.001 | |||||||
| 1-year CCS | 88.4% | 91.7% | 92.3% | 92.1% | 90.6% | 87.3% | 80.6% | |
| 3-year CCS | 70.4% | 76.5% | 77.9% | 79.5% | 78.4% | 75.2% | 67.0% | |
| 5-year CCS | 62.1% | 69.6% | 70.7% | 72.3% | 71.8% | 68.6% | 60.1% | |
| OS | ||||||||
| 1-year OS | 87.4% | 90.9% | 91.6% | 90.8% | 88.0% | 82.3% | 70.7% | |
| 3-year OS | 69.1% | 75.1% | 76.3% | 76.8% | 73.4% | 65.5% | 49.5% | |
| 5-year OS | 60.4% | 67.6% | 68.3% | 68.3% | 64.2% | 54.2% | 35.3% | |
| Non-operated group | (n = 98) | (n = 416) | (n = 1594) | (n = 3150) | (n = 4318) | (n = 6017) | (n = 6647) | |
| CSS | ||||||||
| 1-year CCS | 42.7% | 55.6% | 50.2% | 50.3% | 43.0% | 37.4% | 36.5% | |
| 3-year CCS | 25.2% | 27.2% | 23.4% | 25.6% | 23.3% | 20.7% | 17.0% | |
| 5-year CCS | 21.2% | 20.3% | 18.4% | 19.7% | 18.3% | 16.7% | 11.9% | |
| OS | ||||||||
| 1-year OS | 41.1% | 54.0% | 48.1% | 47.6% | 38.7% | 30.7% | 26.3% | |
| 3-year OS | 21.6% | 25.0% | 21.8% | 23.0% | 19.2% | 14.2% | 8.4% | |
| 5-year OS | 18.2% | 18.0% | 16.4% | 17.0% | 14.0% | 9.8% | 4.3% |